Cellink AB Financials
| CLLKF Stock | USD 2.46 0.35 16.59% |
Cellink |
Understanding current and past Cellink AB Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cellink AB's financial statements are interrelated, with each one affecting the others. For example, an increase in Cellink AB's assets may result in an increase in income on the income statement.
Cellink AB Stock Summary
Cellink AB competes with Brii Biosciences, Venus Medtech, CYBERDYNE, Paxman AB, and NDT Pharmaceuticals. BICO Group AB operates as a bio convergence company in North America, Europe, Asia, and internationally. BICO Group AB was founded in 2016 and is based in Gothenburg, Sweden. Bico Group is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | Arvid Wallgrens Backe |
| Sector | Healthcare |
| Industry | Medical Devices |
| Benchmark | Dow Jones Industrial |
| Website | www.bico.com |
| Phone | 46 7 08 30 08 90 |
| Currency | USD - US Dollar |
Cellink AB Key Financial Ratios
There are many critical financial ratios that Cellink AB's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Cellink AB reports annually and quarterly.| Return On Equity | 0.0068 | |||
| Return On Asset | -0.025 | |||
| Beta | 2.1 |
Cellink Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cellink AB's current stock value. Our valuation model uses many indicators to compare Cellink AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cellink AB competition to find correlations between indicators driving Cellink AB's intrinsic value. More Info.Cellink AB is number one stock in return on equity category among its peers. It is rated second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cellink AB's earnings, one of the primary drivers of an investment's value.Cellink AB Systematic Risk
Cellink AB's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cellink AB volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Cellink AB correlated with the market. If Beta is less than 0 Cellink AB generally moves in the opposite direction as compared to the market. If Cellink AB Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cellink AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cellink AB is generally in the same direction as the market. If Beta > 1 Cellink AB moves generally in the same direction as, but more than the movement of the benchmark.
Cellink AB January 3, 2026 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Cellink AB help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cellink AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cellink AB based on widely used predictive technical indicators. In general, we focus on analyzing Cellink Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cellink AB's daily price indicators and compare them against related drivers.
| Information Ratio | 0.0788 | |||
| Maximum Drawdown | 27.9 | |||
| Value At Risk | (5.67) | |||
| Potential Upside | 9.87 |
Complementary Tools for Cellink Pink Sheet analysis
When running Cellink AB's price analysis, check to measure Cellink AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellink AB is operating at the current time. Most of Cellink AB's value examination focuses on studying past and present price action to predict the probability of Cellink AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellink AB's price. Additionally, you may evaluate how the addition of Cellink AB to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |